✓ Last verified: March 13, 2026 — Edited & verified by Angelica Bottaro for HealingMaps Editorial Staff
Known For: Rochester Hills psychiatric practice led by a Spravato clinical trial investigator, with 30+ years of experience and a 12-member clinical team.
| Review Scores | 4.2/5 on Vitals (129 ratings); established since 1993 with 12+ clinicians |
| Location | Rochester Hills, MI |
| Address | 441 S Livernois Rd, Suite 100, Rochester Hills, MI 48307 |
| Phone | (248) 608-8800 |
| Website | rcbm.net |
| Treatments | Spravato (Esketamine Nasal Spray, REMS-Certified), Psychiatric Evaluation, Medication Management, Psychotherapy |
| Conditions Treated | Treatment-Resistant Depression, Major Depressive Disorder with Suicidal Ideation |
| Cost | Contact clinic for pricing |
| Insurance | Accepts many plans; does not accept TriCare, Carelon, UMR, Blue Care Network, Humana, or Medicaid for Spravato |
| Clinical Lead | Dr. Joel Young, MD (Founder/Medical Director) — Primary Investigator in the Spravato clinical trial |
💡 No clinic-specific pricing posted? See our ketamine therapy cost guide for typical pricing ranges by treatment type and insurance pathways.
HealingMaps Take: Rochester Center for Behavioral Medicine brings a level of clinical credibility that few ketamine providers can match. Dr. Joel Young served as a primary investigator in the Spravato clinical trial — meaning he helped generate the evidence that led to FDA approval. That research pedigree, combined with a practice established in 1993 and a team of 12+ clinicians, creates an exceptionally well-resourced treatment environment. For patients in Oakland County and the northern Detroit suburbs, RCBM offers REMS-certified Spravato backed by the physician who helped prove it works.
Market Position: Rochester Center for Behavioral Medicine is a Spravato-certified clinic in the Hills metro. Spravato (esketamine) is the FDA-approved ketamine treatment that most commercial insurance plans cover after prior authorization — unlike cash-pay IV ketamine.
Industry pricing reference. Rochester Center for Behavioral Medicine has not published specific per-session pricing — contact the clinic directly for a quote. The calculator above shows typical metro-level cost estimates across protocols, not this clinic’s specific prices.
| Protocol | Typical Industry Cost | Offered Here |
|---|---|---|
| IV Ketamine | $350–$650/session | — |
| Spravato (esketamine) | $0–$250 copay (insured) | ✓ Yes |
| IM Ketamine | $250–$400/injection | — |
| KAP (with therapist) | $400–$1,200/session | — |
| At-home troches | $150–$300/month | — |
Sources: CDC PLACES 2023 (Oakland County, MI, crude prevalence) · U.S. Census ACS 5 Year · HealingMaps proprietary patient inquiry data.
Behind this data: HealingMaps has analyzed 23,496 patient inquiries (Oct 2022 – Mar 2026), mapped 1,473 verified clinics across 3,142 counties, scraped 132 clinic pricing pages, and collected 658 practitioner survey responses. This snapshot reflects our multi-source methodology.
Spravato (esketamine) list price is $590 per session cash pay, but commercial-insured patients typically pay $0–$250 in copay after prior authorization — the largest insurance-to-cash gap of any ketamine protocol. Source: HealingMaps 2026 Ketamine Clinic Intelligence Report — drawn from 23,496 patient inquiries and 132 clinic website analyses.
This 2-question summary is matched to the protocols and conditions Rochester Center for Behavioral Medicine treats. Editorial responses are HealingMaps-authored, grounded in our 2026 Ketamine Clinic Intelligence Report.
Yes — Rochester Center for Behavioral Medicine offers Spravato, which means they’re FDA REMS-certified and maintain the required two-hour in-office monitoring window after each dose. Spravato is the primary insurance-covered ketamine option for treatment-resistant depression. Worth confirming the prior-authorization timeline before booking your first session.
Rochester Center for Behavioral Medicine treats depression via Spravato (FDA-approved for TRD). The Spravato pathway is the most likely to obtain commercial insurance coverage. TRD is typically defined as two or more prior antidepressant trials without sufficient response — patients meeting that bar are best candidates here.
View all REMS-certified Spravato clinics in Michigan and across the United States.
Leave a Reply